Riskpilot← Back to searchSign inGet full accessADCARE AS
ASActiveOrg 983847412Strandveien 55, 1366 LysakerWholesale of pharmaceutical and medical goods · NACE 4646Est. 200116 employeeswww.adcare.no
Revenue 2025
NOK 105,6M
+7% vs 2024
EBITDA margin
20.5%
+11% vs 2024
Equity ratio
56.5%
Financial strength
Net profit 2025
NOK 16,3M
+13% vs 2024
| Revenue | NOK 105,6M | +7% |
| EBITDA | NOK 21,6M | +11% |
| Net profit | NOK 16,3M | +13% |
| Total assets | NOK 62M | +21% |
| Equity | NOK 35M | +19% |
| Employees | 16 | — |
Legal name
ADCARE AS
Org number
983847412
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31. oktober 2001
Share capital
NOK 127 500
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Tilby medisinsk utstyr til private- og offentlige sykehus, herunder handel, import/eksport og alt som står i forbindelse hermed, herunder eiendomsdrift og deltakelse i andre selskap.
Address
Strandveien 55, 1366 Lysaker
Phone
+4767533344
Email
firmapost@adcare.no
Website
www.adcare.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 326 | 19 931 | 22 151 | 25 945 | 25 331 | 27 697 | 30 620 | 35 882 | 39 000 | 41 480 | 40 692 | 58 258 | 78 512 | 98 438 | 105 605 |
| Staff expenses | −3 071 | −3 781 | −4 885 | −5 846 | −6 042 | −5 343 | −7 436 | −7 176 | −7 995 | −8 556 | −8 871 | −11 567 | −11 997 | −15 365 | −15 409 |
| EBITDA | 1 195 | 2 165 | 2 639 | 2 550 | 2 076 | 3 090 | 2 259 | 3 742 | 2 288 | 5 696 | 5 827 | 6 571 | 13 563 | 19 565 | 21 648 |
| Depreciation & amort. | −173 | −179 | −222 | −549 | −473 | −526 | −659 | −619 | −757 | −943 | −513 | −646 | −720 | −548 | −603 |
| EBIT | 1 022 | 1 986 | 2 417 | 2 001 | 1 604 | 2 564 | 1 600 | 3 122 | 1 531 | 4 753 | 5 314 | 5 924 | 12 843 | 19 016 | 21 045 |
| Net financials | 76 | 327 | −175 | −708 | −151 | −96 | −98 | −339 | −149 | 669 | 1 031 | 669 | −1 165 | −437 | −135 |
| Profit before tax | 1 098 | 2 313 | 2 242 | 1 293 | 1 453 | 2 468 | 1 502 | 2 783 | 1 382 | 5 422 | 6 346 | 6 594 | 11 677 | 18 579 | 20 911 |
| Tax | 326 | 676 | 646 | 359 | 421 | 635 | 353 | 666 | 338 | 1 199 | 1 402 | 1 454 | 2 578 | 4 102 | 4 620 |
| Net profit | 772 | 1 637 | 1 596 | 934 | 1 032 | 1 833 | 1 149 | 2 117 | 1 044 | 4 224 | 4 943 | 5 140 | 9 099 | 14 477 | 16 290 |
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5 482 | 6 980 | 9 366 | 11 980 | 9 683 | 11 612 | 11 752 | 10 342 | 14 589 | 15 572 | 17 492 | 25 474 | 35 491 | 51 095 | 62 035 |
| Equity | 1 986 | 2 243 | 2 219 | 1 879 | 2 911 | 3 214 | 2 833 | 2 750 | 1 494 | 4 718 | 3 661 | 7 801 | 14 900 | 29 377 | 35 041 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35 |
| Short-term debt | 2 765 | 4 204 | 6 438 | 9 153 | 6 269 | 8 009 | 7 900 | 6 679 | 12 073 | 10 414 | 12 112 | 16 323 | 20 502 | 21 669 | 26 958 |
| Total debt | 3 495 | 4 737 | 7 146 | 10 102 | 6 772 | 8 398 | 8 918 | 7 592 | 13 095 | 10 855 | 13 831 | 17 673 | 20 591 | 21 719 | 26 993 |
EBITDA margin
20.5%
This company
15.8%
Market median
+30% vs market
20112025
Equity ratio
56.5%
This company
38.2%
Market median
+48% vs market
20112025
Return on equity
46.5%
This company
18.4%
Market median
+153% vs market
20112025
Net profit margin
15.4%
This company
8.1%
Market median
+90% vs market
20112025
Asset turnover
1.70×
This company
1.12×
Market median
+52% vs market
20112025
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20112025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RH Deputy Member | Deputy Member | 2017 | — | — |
TG Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Riwimato As | Company | 100.0% | 100.0% | 2022 |
Onemed As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Onemed As
ADCARE AS Board members of ADCARE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rikke Haaland Greibrokk | Deputy Member | 0 companies |
| Torstein Greibrokk | Chief Executive Officer | 0 companies |
| Jan Knoph | Chairman | 0 companies |
| Robert Andrzej Kolakowski | Board of Directors | 0 companies |
| Jens Ole Ørneberg | Board of Directors | 0 companies |